Search Results - "Pascal KE"

Author Correction: BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans.

Authors: Şahin U Muik A Vogler I et al.

Source: Nature [Nature] 2025 Jul; Vol. 643 (8074), pp. E27.

Publication Type: Published Erratum

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE; PubMed not MEDLINE

Low frequency variants can predetermine antiviral drug resistance development in herpes simplex virus type 1.

Authors: Jaki, Lena Full, Florian Gieraths, Udo et al.

Source: PLoS Pathogens. 6/8/2026, Vol. 22 Issue 6, p1-19. 19p.

Neutralization of SARS-CoV-2 by IgM-14 via engagement of two distinct spike epitopes.

Authors: Wang, Yan Hu, Yanping Ku, Zhiqiang et al.

Source: PLoS Pathogens. 3/25/2026, Vol. 22 Issue 3, p1-25. 25p.

Immune-focused RBD nanoparticles induce cross-reactive, RBS-directed responses capable of variant-resistant SARS-CoV-2 neutralization.

Authors: Konrath, Kylie M. Liaw, Kevin Tursi, Nicholas J. et al.

Source: PLoS Pathogens. 2/19/2026, Vol. 22 Issue 2, p1-27. 27p.

Symptom burden, viral load, and antibody response to ancestral SARS-CoV-2 strain [D614G] in an outpatient household cohort.

Authors: Churiwal, Mehal Tompkins, Kathleen Streeter, Gabrielle et al.

Source: PLoS ONE. 2/5/2026, Vol. 21 Issue 2, p1-13. 13p.

Distinct pathways for evolution of enhanced receptor binding and cell entry in SARS-like bat coronaviruses.

Authors: Tse, Alexandra L. Acreman, Cory M. Ricardo-Lax, Inna et al.

Source: PLoS Pathogens. 11/15/2024, Vol. 20 Issue 11, p1-33. 33p.

Interprotomer crosstalk in mosaic viral glycoprotein trimers provides insight into polyvalent immunogen co-assembly.

Authors: Chen, Chengbo Lovendahl, Klaus N. Overbaugh, Julie M. et al.

Source: PLoS Pathogens. 9/22/2025, Vol. 21 Issue 9, p1-22. 22p.

Design and antiviral assessment of a panel of fusion proteins targeting human papillomavirus type 16.

Authors: Bai, Chongzhi Wang, Ruoyu Yang, Qian et al.

Source: PLoS ONE. 10/25/2024, Vol. 19 Issue 10, p1-12. 12p.

Neutralizing monoclonal antibodies against the Gc fusion loop region of Crimean–Congo hemorrhagic fever virus.

Authors: Li, Liushuai Chong, Tingting Peng, Lu et al.

Source: PLoS Pathogens. 2/1/2024, Vol. 20 Issue 2, p1-22. 22p.

Development of a Komagataella phaffii-based expression system for high-activity anti-SARS-CoV-2 neutralizing antibodies.

Authors: Liu, Xueqin Lang, Qiaoli Huang, Nan et al.

Source: AMB Express. 12/11/2025, Vol. 15 Issue 1, p1-13. 13p.

Pair combinations of human monoclonal antibodies fully protected mice against bunyavirus SFTSV lethal challenge.

Authors: Li, Bang Qin, Xiang-rong Qu, Jia-chen et al.

Source: PLoS Pathogens. 1/31/2025, Vol. 21 Issue 1, p1-21. 21p.

SARS-CoV-2 Omicron variations reveal mechanisms controlling cell entry dynamics and antibody neutralization.

Authors: Qing, Enya Salgado, Julisa Wilcox, Alexandria et al.

Source: PLoS Pathogens. 12/2/2024, Vol. 20 Issue 12, p1-24. 24p.

Structural basis and mode of action for two broadly neutralizing nanobodies targeting the highly conserved spike stem-helix of sarbecoviruses including SARS-CoV-2 and its variants.

Authors: Guo, Liyan Chen, Zimin Lin, Sheng et al.

Source: PLoS Pathogens. 4/11/2025, Vol. 21 Issue 4, p1-27. 27p.

Uropathogenic Escherichia coli (UPEC) that hides its identity: features of LC2 and EC73 strains from recurrent urinary tract infections.

Authors: Maurizi, Linda Musleh, Layla Brunetti, Francesca et al.

Source: BMC Microbiology. 8/25/2025, Vol. 25 Issue 1, p1-18. 18p.

Long-term Sequelae in Ebola Virus Disease Survivors Receiving Anti-Ebola Virus Therapies in the Democratic Republic of the Congo: A Prospective Cohort Study.

Authors: Dilu-Keti, Angèle Tovar-Sanchez, Tamara Cuer, Benjamin et al.

Source: Open Forum Infectious Diseases. Aug2025, Vol. 12 Issue 8, p1-13. 13p.

Profiling serum immunodominance following SARS-CoV-2 primary and breakthrough infection reveals distinct variant-specific epitope usage and immune imprinting.

Authors: Seow, Jeffrey Jefferson, George C. E. Keegan, Michael D. et al.

Source: PLoS Pathogens. 11/18/2024, Vol. 20 Issue 11, p1-19. 19p.

Dynamic changes of Bacterial Microbiomes in Oropharynx during Infection and Recovery of COVID-19 Omicron Variant.

Authors: Cui, Guangying Sun, Ying Zou, Yawen et al.

Source: PLoS Pathogens. 4/3/2024, Vol. 20 Issue 4, p1-26. 26p.

N123I mutation in the ALV-J receptor-binding domain region enhances viral replication ability by increasing the binding affinity with chNHE1.

Authors: Yu, Mengmeng Zhang, Yao Zhang, Li et al.

Source: PLoS Pathogens. 2/7/2024, Vol. 20 Issue 2, p1-23. 23p.

Analytical strategies for identification and quantitation of heterodimers in co-formulated monoclonal antibody cocktails by native SEC-MS.

Authors: Peng, Wenjing Yan, Yuetian Cotham, Victoria C. et al.

Source: Scientific Reports. 7/31/2025, Vol. 15 Issue 1, p1-13. 13p.

Delineating the functional activity of antibodies with cross-reactivity to SARS-CoV-2, SARS-CoV-1 and related sarbecoviruses.

Authors: Ruiz, Felicitas Foreman, William B. Lilly, Michelle et al.

Source: PLoS Pathogens. 10/28/2024, Vol. 20 Issue 10, p1-32. 32p.